Circle Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

• Genomic sequencing panels are tests that analyse the DNA of the patient's tumour to look for genetic variants for which there are effective drugs. If the tumour has these variants, treatment can be personalised. • Today, these tests are only useful in 1 in 20 patients in whom they are applied, because most of the time they are used without following clinical recommendations. This is the finding of a study by the CNIO Breast Cancer Clinical Research Unit. • The study shows that when clinical recommendations are followed, genomic sequencing panels increase the efficacy of treatment...

Harvard Inks $30M Deal with Pharmaceutical Company for Therapeutic Research | News | The Harvard Crimson

The new alliance will focus on the development and manufacturing of complex medicines including biologics, vaccines, nucleic acids and cell and gene therapies; as well as looking to launch companies to advance the manufacture of such medicines.

Biomanufacturing technologies company Resilience is partnering with Harvard in a deal that could see innovations from the university’s labs commercialized under new businesses. Resilience has committed $30 million in funding to support Harvard biomanufacturing research.